Tumor Endothelial Cells Induce M2 Macrophage Polarization via IL ‐4, Enhancing Tumor Growth in Hepatocellular Carcinoma
Open Access
- 27 August 2025
- journal article
- Published by Wiley in Cancer Science
- Vol. 116 (11) , 2972-2985
Abstract
Tumor‐associated macrophages (TAMs) and tumor endothelial cells (TECs) are important components in tumor microenvironments. This study examined the interaction between TECs and TAMs in hepatocellular carcinoma (HCC). The aim of this study is to clarify the mechanism of immune suppression and cancer progression mediated by the M2 polarization of TAMs. TECs were isolated from subcutaneous HCC tumors using murine BNL‐T cells, and normal endothelial cells (NECs) were isolated from murine liver. M0 macrophages were obtained from bone marrow after incubation with M‐CSF. Conditioned medium from TECs (TEC CM) or NECs (NEC CM) was added to M0 macrophages, and the polarization to M2 macrophages was assessed. The percentage of iNOS − CD206 + cells was increased in the TEC CM group than in the NEC CM group. The subcutaneous tumor model with co‐injection of BNL‐T and TECs or NECs was applied, and the ratio of M2 macrophages (CD206 + iNOS − CD45 + CD11b + F4/80 + cells) was elevated in the BNL‐T + TEC group. IL‐4 expression in TECs was upregulated compared to NECs, and the secretion of IL‐4 was increased in the TEC CM compared to the NEC CM. After IL‐4 down‐regulation in TECs, the ratio of iNOS − CD206 + cells decreased. The double immunofluorescent staining of CD31 and CD163 was performed in human HCC tissue. The number of CD31 + endothelial cells correlated positively with CD163 + TAMs. The high CD163/CD31 group showed poor prognosis in overall and disease‐free survival. TECs induce M2 macrophage polarization through IL‐4 secretion, leading to immune suppression and cancer progression.Keywords
Funding Information
- Japan Society for the Promotion of Science ((C) 22K08870, (C) 22K16530)
This publication has 40 references indexed in Scilit:
- Lenvatinib‐resistant hepatocellular carcinoma promotes malignant potential of tumor‐associated macrophages via exosomal miR‐301a‐3pAnnals of Gastroenterological Surgery, 2024
- Tumor‐associated macrophages in liver cancer: From mechanisms to therapyCancer Communications, 2022
- New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinomaInternational Journal of Clinical Oncology, 2022
- Inhibition of glycolytic activator PFKFB3 suppresses tumor growth and induces tumor vessel normalization in hepatocellular carcinomaCancer Letters, 2021
- Individualized precision treatment: Targeting TAM in HCCCancer Letters, 2019
- Clinical trials of antiangiogenic therapy for hepatocellular carcinomaInternational Journal of Clinical Oncology, 2016
- Macrophage Plasticity and Polarization in Liver Homeostasis and PathologyHepatology, 2014
- Role of tumor-associated macrophages in the progression of hepatocellular carcinomaSurgery Today, 2011
- HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PlGFCancer Cell, 2011
- Usefulness of the CLIP scoring system for prediction of postoperative prognosis of patients with large hepatocellular carcinomaJournal of Hepato-Biliary-Pancreatic Surgery, 2009